Basis of Allotment

THIS IS A PUBLIC ANNOUNCEMENT FOR INFORMATION PURPOSES ONLY AND IS NOT A PROSPECTUS ANNOUNCEMENT. THIS DOES NOT CONSITUTE AN INVITATION OR OFFER TO ACQUIRE, PURCHASE OR SUBSCRIBE TO SECURITIES.
THIS PUBLIC ANNOUNCEMENT IS NOT INTENDED FOR RELEASE, PUBLICATION OR DISTRIBUTION DIRECTLY OR INDIRECTLY OUTSIDE INDIA.
wpe12.jpg (4842 bytes)
AVIENCE BIOMEDICALS LIMITED
CORPORATE IDENTIFICATION NUMBER: U74999DL2019PLC359158

Our Company was incorporated as Avience Biomedicals Private Limited under the provisions of the Companies Act, 2013 vide certificate of incorporation dated December 23, 2019, in Delhi. Subsequently, our Company was converted into a Public Limited Company pursuant to Shareholders Resolution passed at the Extra Ordinary General Meeting of the Company held on June 26, 2024 and the name of our Company was changed from "Avience Biomedicals Private Limited" to "Avience Biomedicals Limited" vide a fresh Certificate of Incorporation dated September 03, 2024 having CIN U74999DL2019PLC359158 issued by the Registrar of Companies, Central Processing Centre, Delhi. The registered office of our company is situated at C-11, Block-C, Community Centre, Janakpuri A-3, New Delhi-110058, India. For further details, please refer to section titled "Our History and Certain Other Corporate Matters" beginning on page 241 of Prospectus.

Registered Office. C-11, Block-C, Community Centre, Janakpuri A-3, New Delhi- 110058, India
Tel: 1800-12-04-636 Fax: N.A., Website: www.avienbio.com, E-mail: info@avienbio.com
Company Secretary and Compliance Officer: Mr. Manoj Kumar
PROMOTERS: MR. DHARAM DEO CHOUDHARY, MR. RAM NAGINA CHOUDHARY, MR. JANARDAN PAL AND MS. DEEPA CHOUDHARY
Our Company has filed Prospectus dated June 23, 2026 with the Registrar of Companies, Delhi (ROC). The Equity shares are proposed to be listed on the Emerge Platform of National Stock Exchange of India Limited ("NSE Emerge") and trading of the Equity Shares will commence on Thursday, June 25, 2026.
BASIS OF ALLOTMENT

INITIAL PUBLIC ISSUE OF 14,53,800 EQUITY SHARES OF FACE VALUE OF RS. 10/- EACH ("THE EQUITY SHARES") OF AVIENCE BIOMEDICALS LIMITED ("OUR COMPANY" OR "ABL" OR THE "ISSUER") AT AN ISSUE PRICE OF RS. 208 PER EQUITY SHARE FOR CASH, AGGREGATING TO RS. 3,023.90 LAKHS ("PUBLIC ISSUE") OUT OF WHICH 82,200 EQUITY SHARES OF FACE VALUE OF RS. 10 EACH, AT AN ISSUE PRICE OF RS. 208 PER EQUITY SHARE FOR CASH, AGGREGATING TO RS. 170.98 LAKHS WILL BE RESERVED FOR SUBSCRIPTION BY THE MARKET MAKER TO THE ISSUE (THE "MARKET MAKER RESERVATION PORTION"). THE PUBLIC ISSUE LESS MARKET MAKER RESERVATION PORTION I.E. ISSUE OF 13,71,600 EQUITY SHARES OF FACE VALUE OF RS. 10 EACH, AT AN ISSUE PRICE OF RS. 208 PER EQUITY SHARE FOR CASH, AGGREGATING TO RS. 2,852.93 LAKHS IS HEREIN AFTER REFERRED TO AS THE "NET ISSUE". THE PUBLIC ISSUE AND NET ISSUE WILL CONSTITUTE 26.50% AND 25.01% % RESPECTIVELY OF THE POST- ISSUE PAID-UP EQUITY SHARE CAPITAL OF OUR COMPANY.

THE FACE VALUE OF THE EQUITY SHARE IS RS. 10 EACH AND THE ISSUE PRICE IS RS. 208/-
ANCHOR INVESTOR ISSUE PRICE: RS. 208/- PER EQUITY SHARE
THE ISSUE PRICE IS 20.8 TIMES OF THE FACE VALUE OF THE EQUITY SHARES.
RISKS TO INVESTORS

The pharmaceutical market is subject to extensive regulation and failures to comply with the existing and future regulatory requirements in any pharmaceutical market could expose us to litigation or other liabilities, which could adversely affect our reputation, business, financial condition and results of operations.

We are dependent on certain customers for a portion of our revenues. The loss of any of our major customers due to any adverse development or significant reduction in business from our major customers may adversely affect our business, financial condition, results of operations and future prospects.

We rely on suppliers for medical devices and equipment manufacturers for our trading goods, and also face risks in sourcing raw materials and components from third parties for the manufacturing and assembly of our medical equipment. Any disruption in the supply of these goods or materials could adversely impact our business, operations, and financial condition.

Our Financial Statement as Restated are prepared and signed by the Peer Review Auditor who is not Statutory Auditors of our Company as required under the provisions of ICDR.

Our business derives a significant portion of its revenue from the trading sector, and any potential instability in this area could pose a risk to our overall performance.

For details about the risk faced by our company kindly refer to the chapter titled "Risk Factors" beginning on Page 28 of Prospectus.

BID/ISSUE PROGRAMME ANCHOR INVESTOR BIDDING DATE: WEDNESDAY, JUNE 17, 2026
BID/ISSUE OPENED ON: THURSDAY, JUNE 18, 2026
BID/ISSUE CLOSED ON: MONDAY, JUNE 22, 2026

This Issue is being made through the Book Building Process, in terms of Rule 19(2) (b) of the Securities Contracts (Regulation) Rules, 1957, as amended ("SCRR") read with Regulation 229 of the SEBI ICDR Regulations and in compliance with Regulation 253 of the SEBI ICDR Regulations, wherein not more than 50.00% of the Net Issue shall be available for allocation on a proportionate basis to Qualified Institutional Buyers ("QIBs") (the "QIB Portion"), provided that our Company may, in consultation with the Book Running Lead Manager, may allocate up to 60% of the QIB Portion to Anchor Investors on a discretionary basis in accordance with the SEBI ICDR Regulations ("Anchor Investor Portion"), of which one-third shall be reserved for domestic Mutual Funds, subject to valid Bids being received from domestic Mutual Funds at or above the Anchor Investor Allocation Price. In the event of under-subscription, or non-allocation in the Anchor Investor Portion, the balance Equity Shares shall be added to the Net QIB Portion. Further, 5.00% of the Net QIB Portion shall be available for allocation on a proportionate basis to Mutual Funds only, and the remainder of the Net QIB Portion shall be available for allocation on a proportionate basis to all QIB Bidders, including Mutual Funds, subject to valid Bids being received at or above the Issue Price. However, if the aggregate demand from Mutual Funds is less than 5.00% of the Net QIB Portion, the balance Equity Shares available for allocation in the Mutual Fund Portion will be added to the remaining Net QIB Portion for proportionate allocation to QIBs. Further, not less than 15.00% of the Net Issue shall be available for allocation on a proportionate basis to Non-Institutional Investors out of which (a) one third of such portion is reserved for applicants with application size of more than 2 lots and up to such lots equivalent to not more than Rs. 10,00,000 and (b) two-third of such portion was reserved for applicants with application size of more than Rs. 10,00,000 provided that the unsubscribed portion in either of such subcategories could have been allocated to applicants in the other sub-category of Non-Institutional Bidders and not less than 35.00% of the Net Issue shall be available for allocation to Individual Investors who applies for minimum application size in accordance with the SEBI ICDR Regulations, subject to valid Bids being received from them at or above the Issue Price. All Bidders are required to participate in the Issue by mandatorily utilizing the Application Supported by Blocked Amount ("ASBA") process by providing details of their respective ASBA Account (as defined hereinafter) in which the corresponding Bid Amounts will be blocked by the Self Certified Syndicate Banks ("SCSBs") or under the UPI Mechanism, as the case may be, to the extent of respective Bid Amounts. Anchor Investors are not permitted to participate in the Issue through the ASBA process. For details, see "Issue Procedure" on page 349 of Prospectus.

SUBSCRIPTION DETAILS

The Company received 4 Anchor Investor Application Forms from 4 Anchor Investors for 4,58,400 Equity Shares. Out of such 4 Anchor Investors through 4 Anchor Investor Application Forms were allocated 4,09,800 Equity Shares at a price of Rs. 208/- per Equity Share under the Anchor Investor Portion, aggregating to Rs. 852.38 Lakhs.

DETAILS OF APPLICATIONS

The Issue was subscribed to the extent of 386.99 times (excluding the Anchor Investor Portion) as per the bid books of NSE (the "Bid Files") after removing multiple and duplicate bids.

After removing multiple and duplicate bids, bids (UPI Mandates) not accepted by investors / blocked, bids rejected under application banked but bid not registered and valid rejections cases from the 'Bid Book', the Issue was subscribed 351.67 times (excluding the Anchor Investor Portion).

The Issue has received 1,93,726 applications, excluding Anchor Investors, (before valid rejections) for 37,20,49,800 equity shares. The details of the applications received in the issue (before technical rejections but after applications not banked) are as follows:

Details of the Applications Received:

Sr. No. Category Number of Number of Amount (Rs.)
Applications Equity Shares
1 Qualified Institutional Buyers- Mutual Fund 2 3,36,000 6,98,88,000.00
2 Qualified Institutional Buyers- Others 83 5,30,59,800 11,03,64,38,400.00
3 Non-Institutional Investors 1 (not more than Rs. 1,000,000/-) 15,426 3,13,23,600 6,51,49,05,000.00
4 Non-Institutional Investors 2 (More than Rs. 1,000,000/-) 16,649 9,33,70,200 19,42,07,31,600.00
5 Market Maker 1 82,200 1,70,97,600.00
6 Individual Investors 1,61,565 19,38,78,000 40,32,17,13,600.00
TOTAL 1,93,726 37,20,49,800 77,38,07,74,200.00

Final Demand:

A Summary of the final demand as per NSE as on the Bid/ Issue Date at different Bid Prices is as under:

Sr. No. Price Bids Shares Applied Amount Applied
1 196.00 253 3,15,600 6,18,57,600.00
2 197.00 14 16,800 33,09,600.00
3 198.00 16 19,800 39,20,400.00
4 199.00 4 4,800 9,55,200.00
5 200.00 58 70,800 1,41,60,000.00
6 201.00 8 9,600 19,29,600.00
7 202.00 5 6,000 12,12,000.00
8 203.00 43 93,600 1,90,00,800.00
9 204.00 10 12,000 24,48,000.00
10 205.00 17 20,400 41,82,000.00
11 206.00 22 36,600 75,39,600.00
12 207.00 37 49,800 1,03,08,600.00
13 208.00 1,93,219 37,13,70,000 77,24,49,60,000.00
Total 1,93,706 37,20,25,800 77,37,57,83,400.00

The Basis of Allotment was finalized in consultation with the Designated Stock Exchange, being National Stock Exchange of India Limited on June 23, 2026.

A. Allocation to Market Maker (After Technical Rejections & Withdrawal): The Basis of Allotment to the Market Maker, at the issue price of Rs. 208/- per Equity Share, was finalized in consultation with NSE. The category was subscribed by 1.00 times. The total number of shares allotted in this category is 82,200 Equity shares.

The category wise details of the Basis of Allotment are as under:

Sr. No. No. of Shares applied for (Category Wise) Number of applications received % to Total Total No. of Shares applied in each category % to Total Proportionanate shares available Allocation per Applicant Ratio of allottees to applicants Number of Successful applicants (after rounding off) % to Total Total No. of Shares allocated/ allotted % to Total Surplus/ Deficit (13)-(7)
(1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15)
1 82,200 1 100.00 82,200 100.00 82,200 82,200 82,200 1 1 1 100.00 82,200 100.00 0
TOTAL 1 100.00 82,200 100.00 82,200 1 100.00 82,200 100.00 0

B. Allocation to Individual Investors (After Technical Rejections & Withdrawal): The Basis of Allotment to the Individual Investors, at the issue price of Rs. 208/- per Equity Share, was finalized in consultation with NSE. The category was subscribed 394.72 times i.e. 1,58,284 applications received for 18,99,40,800 Equity Shares. The total number of shares allotted in this category is 4,81,200 Equity Shares to 401 successful applicants.

The category wise details of the Basis of Allotment are as under:

Sr. No. No. of Shares applied for (Category Wise) Number of application s received % to Total Total No. of Shares applied in each category % to Total Proportionanate shares available Allocation per Applicant Ratio of allottees to applicants Number of Successful applicants (after rounding off) % to Total Total No. of Shares allocated/ allotted % to Total Surplus/ Deficit (13)-(7)
(1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15)
1 1,200 158284 100.00 18,99,40,800 100.00 4,81,200 3 1,200 401 158284 401 100.00 4,81,200 100.00 0
TOTAL 1,58,284 100.00 18,99,40,800 100.00 4,81,200 401 100.00 4,81,200 100.00 0

C. Allocation to Non -Institutional Investors (After Technical Rejections & Withdrawal):

Non-Institutional Investors upto Rs. 10 Lakhs: The Basis of Allotment to Other than Individual Investors, who have bid at the issue price of Rs. 208/- per Equity Share, was finalized in consultation with NSE. The category I (above 2 lots & up to 10,00,000/-) was subscribed by 448.63 times i.e. 15,251 applications received for 3,09,55,200 equity shares & the total number of shares allotted in this category is 69,000 Equity Shares to 38 successful applicants.

The category wise details of the Basis of Allotment are as under:

Sr. No. No. of Shares applied for (Category Wise) Number of applications received % to Total Total No. of Shares applied in each category % to Total Proportionanat e shares available Allocation per Applicant Ratio of allottees to applicants Number of Successful applicants (after rounding off) % to Total Total No. of Shares allocated/ allotted % to Total Surplus/ Deficit (13)-(7)
(1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15)
1 1,800 12240 80.26 2,20,32,000 71.17 55,377 5 1,800 31 12240 31 81.58 55,800 80.87 423
2 2,400 1960 12.85 47,04,000 15.20 8,868 5 1,800 1 392 5 13.16 9,000 13.04 132
3 3,000 271 1.78 8,13,000 2.63 1,226 5 1,800 1 271 1 2.63 1,800 2.61 574
4 3,600 235 1.54 8,46,000 2.73 1,063 5 1,800 0 235 0 0.00 0 0.00 -1,063
5 4,200 93 0.61 3,90,600 1.26 421 5 1,800 0 93 0 0.00 0 0.00 -421
6 4,800 452 2.96 21,69,600 7.01 2,045 5 1,800 1 452 1 2.63 1,800 2.61 -245
Serial No 2 & 3,6 Shall be allocated 600 Shares 1 7 0 0.00 600 0.87 600
TOTAL 15,251 100.00 3,09,55,200 100.00 69,000 38 100.00 69,000 100.00 -0

Non-Institutional Investors above Rs. 10 Lakhs: The Basis of Allotment to Other than Individual Investors, who have bid at the issue price of Rs. 208/- per Equity Share, was finalized in consultation with NSE. The category II (above 10,00,000/-) was subscribed by 672.26 times i.e. 16,545 applications received for 9,27,72,000 equity shares & the total number of shares allotted in this category is 1,38,000 Equity Shares to 76 successful applicants.

The category wise details of the Basis of Allotment are as under:

Sr. No. No. of Shares applied for (Category Wise) Number of applications received % to Total Total No. of Shares applied in each category % to Total Proportionanate shares available Allocation per Applicant Ratio of allottees to applicants Number of Successful applicants (after rounding off) % to Total Total No. of Shares allocated/ allotted % to Total Surplus/ Deficit (13)-(7)
(1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15)
1 5,400 15794 95.46 8,52,87,600 91.93 1,31,736 8 1,800 73 15794 73 96.05 1,31,400 95.22 -336
2 6,000 352 2.13 21,12,000 2.28 2,936 8 1,800 1 176 2 2.63 3,600 2.61 664
3 6,600 72 0.44 4,75,200 0.51 601 8 1,800 0 72 0 0.00 0 0.00 -601
4 7,200 43 0.26 3,09,600 0.33 359 8 1,800 0 43 0 0.00 0 0.00 -359
5 7,800 22 0.13 1,71,600 0.18 183 8 1,800 0 22 0 0.00 0 0.00 -183
6 8,400 18 0.11 1,51,200 0.16 150 8 1,800 0 18 0 0.00 0 0.00 -150
7 9,000 8 0.05 72,000 0.08 67 8 1,800 0 8 0 0.00 0 0.00 -67
8 9,600 16 0.10 1,53,600 0.17 133 8 1,800 0 16 0 0.00 0 0.00 -133
9 10,200 14 0.08 1,42,800 0.15 117 8 1,800 0 14 0 0.00 0 0.00 -117
10 10,800 53 0.32 5,72,400 0.62 442 8 1,800 0 53 0 0.00 0 0.00 -442
11 11,400 10 0.06 1,14,000 0.12 83 8 1,800 0 10 0 0.00 0 0.00 -83
12 12,000 33 0.20 3,96,000 0.43 275 8 1,800 0 33 0 0.00 0 0.00 -275
13 12,600 8 0.05 1,00,800 0.11 67 8 1,800 0 8 0 0.00 0 0.00 -67
14 13,200 5 0.03 66,000 0.07 42 8 1,800 0 5 0 0.00 0 0.00 -42
15 13,800 2 0.01 27,600 0.03 17 8 1,800 0 2 0 0.00 0 0.00 -17
16 14,400 6 0.04 86,400 0.09 50 8 1,800 0 6 0 0.00 0 0.00 -50
17 15,000 5 0.03 75,000 0.08 42 8 1,800 0 5 0 0.00 0 0.00 -42
18 15,600 5 0.03 78,000 0.08 42 8 1,800 0 5 0 0.00 0 0.00 -42
19 16,200 8 0.05 1,29,600 0.14 67 8 1,800 0 8 0 0.00 0 0.00 -67
20 16,800 4 0.02 67,200 0.07 33 8 1,800 0 4 0 0.00 0 0.00 -33
21 17,400 1 0.01 17,400 0.02 8 8 1,800 0 1 0 0.00 0 0.00 -8
22 18,000 7 0.04 1,26,000 0.14 58 8 1,800 0 7 0 0.00 0 0.00 -58
23 18,600 1 0.01 18,600 0.02 8 8 1,800 0 1 0 0.00 0 0.00 -8
24 19,800 2 0.01 39,600 0.04 17 8 1,800 0 2 0 0.00 0 0.00 -17
25 20,400 1 0.01 20,400 0.02 8 8 1,800 0 1 0 0.00 0 0.00 -8
26 21,000 7 0.04 1,47,000 0.16 58 8 1,800 0 7 0 0.00 0 0.00 -58
27 21,600 3 0.02 64,800 0.07 25 8 1,800 0 3 0 0.00 0 0.00 -25
28 22,200 1 0.01 22,200 0.02 8 8 1,800 0 1 0 0.00 0 0.00 -8
29 22,800 2 0.01 45,600 0.05 17 8 1,800 0 2 0 0.00 0 0.00 -17
30 23,400 3 0.02 70,200 0.08 25 8 1,800 0 3 0 0.00 0 0.00 -25
31 24,000 5 0.03 1,20,000 0.13 42 8 1,800 0 5 0 0.00 0 0.00 -42
32 25,200 1 0.01 25,200 0.03 8 8 1,800 0 1 0 0.00 0 0.00 -8
33 25,800 2 0.01 51,600 0.06 17 8 1,800 0 2 0 0.00 0 0.00 -17
34 27,000 2 0.01 54,000 0.06 17 8 1,800 0 2 0 0.00 0 0.00 -17
35 27,600 1 0.01 27,600 0.03 8 8 1,800 0 1 0 0.00 0 0.00 -8
36 28,800 1 0.01 28,800 0.03 8 8 1,800 0 1 0 0.00 0 0.00 -8
37 29,400 2 0.01 58,800 0.06 17 8 1,800 0 2 0 0.00 0 0.00 -17
38 30,000 1 0.01 30,000 0.03 8 8 1,800 0 1 0 0.00 0 0.00 -8
39 30,600 2 0.01 61,200 0.07 17 8 1,800 0 2 0 0.00 0 0.00 -17
40 31,800 1 0.01 31,800 0.03 8 8 1,800 0 1 0 0.00 0 0.00 -8
41 36,000 1 0.01 36,000 0.04 8 8 1,800 0 1 0 0.00 0 0.00 -8
42 37,800 2 0.01 75,600 0.08 17 8 1,800 0 2 0 0.00 0 0.00 -17
43 38,400 1 0.01 38,400 0.04 8 8 1,800 0 1 0 0.00 0 0.00 -8
44 40,800 1 0.01 40,800 0.04 8 8 1,800 0 1 0 0.00 0 0.00 -8
45 43,200 1 0.01 43,200 0.05 8 8 1,800 0 1 0 0.00 0 0.00 -8
46 47,400 1 0.01 47,400 0.05 8 8 1,800 0 1 0 0.00 0 0.00 -8
47 48,000 2 0.01 96,000 0.10 17 8 1,800 0 2 0 0.00 0 0.00 -17
48 48,600 1 0.01 48,600 0.05 8 8 1,800 0 1 0 0.00 0 0.00 -8
49 49,200 1 0.01 49,200 0.05 8 8 1,800 0 1 0 0.00 0 0.00 -8
50 52,200 1 0.01 52,200 0.06 8 8 1,800 0 1 0 0.00 0 0.00 -8
51 52,800 1 0.01 52,800 0.06 8 8 1,800 0 1 0 0.00 0 0.00 -8
52 54,000 2 0.01 1,08,000 0.12 17 8 1,800 0 2 0 0.00 0 0.00 -17
53 59,400 1 0.01 59,400 0.06 8 8 1,800 0 1 0 0.00 0 0.00 -8
54 60,000 1 0.01 60,000 0.06 8 8 1,800 0 1 0 0.00 0 0.00 -8
55 60,600 1 0.01 60,600 0.07 8 8 1,800 0 1 0 0.00 0 0.00 -8
56 70,200 1 0.01 70,200 0.08 8 8 1,800 0 1 0 0.00 0 0.00 -8
57 84,000 1 0.01 84,000 0.09 8 8 1,800 0 1 0 0.00 0 0.00 -8
58 1,00,200 1 0.01 1,00,200 0.11 8 8 1,800 0 1 0 0.00 0 0.00 -8
- Serial No 4 to 58 1800 Shares were Allocated 0 1,800 1 399 1 1.32 1,800 1.30 1,800
Serial No 1 to 2 1200 Shares were allocated 0 600 2 76 0 0.00 1,200 0.87 1,200
TOTAL 16,545 100.00 9,27,72,000 100.00 1,38,000 76 100.00 1,38,000 100.00 -0

D. Allocation to QIB Category- Mutual Fund (Excluding Anchor Investor) (After Technical Rejections & Withdrawal):

The Basis of Allotment to the Qualified Institutional Buyers-Mutual Funds (Excluding Anchor Investor), at the issue price of Rs. 208/- per Equity Share, was finalized in consultation with NSE. The category was subscribed by 24.35 times i.e. 2 applications received for 3,36,000 equity shares & the total number of shares allotted in this category is 13,800 equity Shares to 2 successful applicants.

The category wise details of the Basis of Allotment are as under:

Sr. No. No. of Shares applied for (Category Wise) Number of applications received % to Total Total No. of Shares applied in each category % to Total Proportionanate shares available Allocation per Applicant Ratio of allottees to applicants Number of Successful applicants (after rounding off) % to Total Total No. of Shares allocated/ allotted % to Total Surplus/ Deficit (13)-(7)
(1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15)
1 96,000 1 50.00 96,000 28.57 3,943 3,943 4,200 1 1 1 50.00 4,200 30.43 257
2 2,40,000 1 50.00 2,40,000 71.43 9,857 9,857 9,600 1 1 1 50.00 9,600 69.57 -257
TOTAL 2 100.00 3,36,000 100.00 13,800 2 100.00 13,800 100.00 0

E. Allocation to QIB Category- Other than Mutual Fund (Excluding Anchor Investor) (After Technical Rejections & Withdrawal):

The Basis of Allotment to the Qualified Institutional Buyers-Other than Mutual Funds (Excluding Anchor Investor), at the issue price of Rs. 208/- per Equity Share, was finalized in consultation with NSE. The category was subscribed by 204.23 times i.e. 83 applications received for 5,30,59,800 equity shares & the total number of shares allotted in this category is 2,59,800 Equity Shares to 72 successful applicants.

The category wise details of the Basis of Allotment are as under:

Sr. No. No. of Shares applied for (Category Wise) Number of applications received % to Total Total No. of Shares applied in each category % to Total Proportiona- nate shares available Allocation per Applicant Ratio of allottees to applicants Number of Successful applicants (after rounding off) %to Total Total No. of Shares allocated/ allotted % to Total Surplus/ Deficit (13)-(7)
(1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15)
1 48,600 2 2.41 97,200 0.18 476 238 1,800 0 1 0 0.00 0 0.00 -476
2 72,000 1 1.20 72,000 0.14 353 353 1,800 0 1 0 0.00 0 0.00 -353
3 82,200 1 1.20 82,200 0.15 402 402 1,800 0 1 0 0.00 0 0.00 -402
4 1,01,400 1 1.20 1,01,400 0.19 496 496 1,800 0 1 0 0.00 0 0.00 -496
5 1,10,400 1 1.20 1,10,400 0.21 541 541 1,800 0 1 0 0.00 0 0.00 -541
6 1,16,400 1 1.20 1,16,400 0.22 570 570 1,800 0 1 0 0.00 0 0.00 -570
7 1,17,600 1 1.20 1,17,600 0.22 576 576 1,800 0 1 0 0.00 0 0.00 -576
8 1,44,600 1 1.20 1,44,600 0.27 708 708 1,800 0 1 0 0.00 0 0.00 -708
9 1,45,800 1 1.20 1,45,800 0.27 714 714 1,800 0 1 0 0.00 0 0.00 -714
10 1,53,000 1 1.20 1,53,000 0.29 749 749 1,800 0 1 0 0.00 0 0.00 -749
11 1,92,600 1 1.20 1,92,600 0.36 943 943 1.800 1 1 1 1.39 1,800 0.69 857
12 1,93,800 1 1.20 1,93,800 0.37 949 949 1,800 1 1 1 1.39 1,800 0.69 851
13 2,10,000 1 1.20 2,10,000 0.40 1,028 1,028 1,800 1 1 1 1.39 1,800 0.69 772
14 2,13,000 1 1.20 2,13,000 0.40 1,043 1,043 1,800 1 1 1 1.39 1,800 0.69 757
15 2,34,600 1 1.20 2,34,600 0.44 1,149 1,149 1,800 1 1 1 1.39 1,800 0.69 651
16 2,40,000 1 1.20 2,40,000 0.45 1,175 1,175 1,800 1 1 1 1.39 1,800 0.69 625
17 2,40,600 1 1.20 2,40,600 0.45 1,178 1,178 1,800 1 1 1 1.39 1,800 0.69 622
18 2,64,600 1 1.20 2,64,600 0.50 1,296 1,296 1,800 1 1 1 1.39 1.800 0.69 504
19 2,71,800 1 1.20 2,71,800 0.51 1,331 1,331 1,800 1 1 1 1.39 1,800 0.69 469
20 3,00,600 1 1.20 3,00,600 0.57 1,472 1,472 1,800 1 1 1 1.39 1,800 0.69 328
21 3,06,000 1 1.20 3,06,000 0.58 1,498 1,498 1,800 1 1 1 1.39 1,800 0.69 302
22 3,45,600 1 1.20 3,45,600 0.65 1,692 1,692 1,800 1 1 1 1.39 1,800 0.69 108
23 3,84,600 2 2.41 7,69,200 1.45 3,766 1,883 1,800 1 1 2 2.78 3,600 1.39 -166
24 4,02,000 1 1.20 4,02,000 0.76 1,968 1,968 1,800 1 1 1 1.39 1.800 0.69 -168
25 4,23,600 1 1.20 4,23,600 0.80 2,074 2,074 1,800 1 1 1 1.39 1,800 0.69 -274
26 4,71,000 1 1.20 4,71,000 0.89 2,306 2,306 2,400 1 1 1 1.39 2,400 0.92 94
27 4,95,000 1 1.20 4,95,000 0.93 2,424 2,424 2,400 1 1 1 1.39 2,400 0.92 -24
28 5,01,000 1 1.20 5,01,000 0.94 2,453 2,453 2,400 1 1 1 1.39 2,400 0.92 -53
29 5,04,600 1 1.20 5,04,600 0.95 2,471 2,471 2,400 1 1 1 1.39 2,400 0.92 -71
30 5,19,000 1 1.20 5,19,000 0.98 2,541 2,541 2,400 1 1 1 1.39 2,400 0.92 -141
31 5,24,400 1 1.20 5,24,400 0.99 2,568 2,568 2,400 1 1 1 1.39 2.400 0.92 -168
32 5,43,000 1 1.20 5,43,000 1.02 2,659 2,659 2,400 1 1 1 1.39 2,400 0.92 -259
33 5,46,000 1 1.20 5,46,000 1.03 2,673 2,673 2,400 1 1 1 1.39 2,400 0.92 -273
34 5,48,400 2 2.41 10,96,800 2.07 5,370 2,685 2,400 1 1 2 2.78 4,800 1.85 -570
5,48,400 0 0.00 0 0.00 0 0 600 1 2 0 0.00 600 0.23 600
35 5,62,800 1 1.20 5,62,800 1.06 2,756 2,756 3,000 1 1 1 1.39 3,000 1.15 244
36 6,48,000 1 1.20 6,48,000 1.22 3,173 3,173 3,000 1 1 1 1.39 3,000 1.15 -173
37 6,51,000 1 1.20 6,51,000 1.23 3,188 3,188 3,000 1 1 1 1.39 3,000 1.15 -188
38 6,72,000 1 1.20 6,72,000 1.27 3,290 3,290 3,600 1 1 1 1.39 3,600 1.39 310
39 7,21,200 1 1.20 7,21,200 1.36 3,531 3,531 3,600 1 1 1 1.39 3,600 1.39 69
40 7,30,200 1 1.20 7,30,200 1.38 3,575 3,575 3,600 1 1 1 1.39 3,600 1.39 25
41 8,17,200 1 1.20 8,17,200 1.54 4,001 4,001 4,200 1 1 1 1.39 4,200 1.62 199
42 8,90,400 1 1.20 8,90,400 1.68 4,360 4,360 4,200 1 1 1 1.39 4,200 1.62 -160
43 9,01,800 1 1.20 9,01,800 1.70 4,416 4,416 4,200 1 1 1 1.39 4,200 1.62 -216
44 9,13,800 1 1.20 9,13,800 1.72 4,474 4,474 4,200 1 1 1 1.39 4,200 1.62 -274
45 9,48,600 1 1.20 9,48,600 1.79 4,645 4,645 4,800 1 1 1 1.39 4,800 1.85 155
46 9,60,000 3 3.61 28,80,000 5.43 14,102 4,701 4,800 1 1 3 4.17 14,400 5.54 298
47 9,61,200 7 8.43 67,28,400 12.68 32,945 4,706 4,200 1 1 7 9.72 29,400 11.32 -3,545
9,61,200 0 0.00 0 0.00 0 0 600 6 7 0 0.00 3,600 1.39 3,600
48 9,61,800 25 30.12 2,40,45,000 45.32 1,17,733 4,709 3,600 1 1 25 34.72 90,000 34.64 -27,733
9,61,800 0 0.00 0 0.00 0 0 1,200 23 25 0 0.00 27,600 10.62 27,600
TOTAL 83 100.00 5,30,59,800 100.00 2,59,800 72 100.00 2,59,800 100.00 0

F. Allocation to Anchor Investor (After Technical Rejection): The company in consultation with BRLMs had allotted 4,09,800 Equity Shares to 4 (Four) Anchor Investor at an Issue price of Rs. 208/- per share in accordance with SEBI (ICDR) Regulations, 2018.

The category-wise details of Basis of Allotment are as follows:

Category FIS/Banks MF's VCF NBFC's AIF FPI Others Total
Allotment - - - 48,600 2,40,600 1,20,600 - 4,09,800

The Board of Directors of the Company at its meeting held on June 23, 2026, has approved the Basis of Allocation of Equity Shares as approved by the Designated Stock Exchange viz. NSE and has authorized the corporate action for issue of the Equity Shares to various successful applicants.

The CAN-cum-allotment advices and/or notices will be forwarded to the email id's and address of the Applicants as registered with the depositories / as filled in the application form on or before June 24, 2026. Further, the instructions to Self-Certified Syndicate Banks for unblocking the amount will be processed on or prior to June 24, 2026. In case the same is not received within 10 days, investors may contact at the address given below. The Equity Shares allocated to successful applicants are being credited to their beneficiary accounts subject to validation of the account details with the depositories concerned. The Company is taking steps to get the Equity Shares admitted for trading on the Emerge Platform of National Stock Exchange of India Limited (NSE Emerge) within three working days from the date of the closure of the Issue.

Note: All capitalized terms used and not defined herein shall have the respective meanings assigned to them in the Prospectus dated June 23, 2026 ("Prospectus").

INVESTORS, PLEASE NOTE

The details of the allotment made would also be hosted on the website of the Registrar to the Issue, SKYLINE FINANCIAL SERVICES PRIVATE LIMITED at https://www.skylinerta.com/.AII future correspondence in this regard may kindly be addressed to the Registrar to the Issue quoting full name of the First/ Sole applicants, serial number of the Application Form, number of shares applied for and Bank Branch where the application had been lodged and payment details at the address of the Registrar given below:

wpe13.jpg (4240 bytes) REGISTRAR TO THE ISSUE
SKYLINE FINANCIAL SERVICES PRIVATE LIMITED
Address: D-153A, First Floor, Okhla Industrial Area, Phase-I, New Delhi-110020
Telephone: 011-40450193-197 | Email: ipo@skylinerta.com | Website: https://www.skylinerta.com/
Contact Person: Mr. Anuj Rana | SEBI Registration Number: INR000003241
CIN: U74899DL1995PTC071324
CORRIGENDUM: NOTICE TO INVESTORS

This Corrigendum should be read with the Prospectus dated June 23, 2026.

1. In the chapter titled "CAPITAL STRUCTURE", under the heading "OUR SHAREHOLDING PATTERN" appearing on page 84 of the Prospectus, in the table presenting the current shareholding pattern of our Company as on the date of the Prospectus, the number of Locked-in Shares (XII) shall be read as follows:

Under the Promoter & Promoter Group Category: 35,42,885 Equity Shares.

Under the Public Category: 4,88,371 Equity Shares, constituting 87.89% and 12.11 %, respectively, of the total shares held.

2. In the chapter titled "CAPITAL STRUCTURE", under the heading "OUR SHAREHOLDING PATTERN" appearing on page 84 of the Prospectus, in the table presenting the current shareholding pattern of our Company as on the date of the Prospectus, the number of Public Shareholders to be read as 32 instead of 31 and the Total Number of Shareholders of the Company to be read as 39 instead of 38.

3. In the chapter titled "CAPITAL STRUCTURE" and "OUR HISTORY AND CERTAIN OTHER CORPORATE MATTERS", appearing on page no. 89 and 241 respectively of the Prospectus, the total number of Shareholders shall be read as 39 (Thirty-Nine) shareholders instead of 38 (Thirty-Eight) Shareholders, as of the date of Prospectus.

This Corrigendum should be read with the Red Herring Prospectus dated June 12, 2026.

4. In the chapter titled "OBJECTS OF THE ISSUE", under the heading "UTILISATION OF NET ISSUE PROCEEDS" appearing on page 95 and "SCHEDULE OF IMPLEMENTATION AND DEPLOYMENT OF FUNDS" appearing on page 126 of Red Herring Prospectus the amount mentioned as "Rs. 1,595.53 Lakhs" shall be read as "Rs. 1,404.53 Lakhs" and the amount mentioned as "Rs. 222.93 Lakhs" shall be read as "Rs. 413.93 Lakhs" respectively.

For Avience Biomedicals Limited
On Behalf of the Board of Directors
Sd/-
Place: New Delhi Dharam Deo Choudhary
Date: June 24, 2026 (Managing Director)

THE LEVEL OF SUBSCRIPTION SHOULD NOT BE TAKEN TO BE INDICATIVE OF EITHER THE MARKET PRICE OF THE EQUITY SHARES ON LISTING OR THE BUSINESS PROSPECTS OF AVIENCE BIOMEDICALS LIMITED.

Note: All capitalized terms used and not defined herein shall have same meanings assigned to them in the Prospectus.

Disclaimer: Avience Biomedicals Limited has filed the Prospectus with ROC on June 23, 2026, and thereafter with SEBI and Stock Exchanges. The Prospectus is available on the Website of SEBI at www.sebi.gov.in and website of BRLM i.e., Fintellectual Corporate Advisors Private Limited at https://fintellectualadvisors.com. Investors should note that investment Equity Shares involve a high degree of risk and for details relating to the same, please see "Risk Factor" beginning on page 28 of the Prospectus.

The Equity Shares have not been and will not be registered under U.S. Securities Act of 1993, as amended ("the Securities Act") or any state securities laws in the United States, and unless so registered, and may not be offered or sold within United States, except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in accordance with any applicable U.S. state securities laws. The Equity Shares are being offered and sold outside the United States in 'offshore transactions' in reliance on Regulations under Securities Act and the applicable laws of each jurisdiction where such offers and sales were made. There will be no public offering in the United States.